J R Soc Med 2003;96:389-392
doi:10.1258/jrsm.96.8.389
© 2003 Royal Society of Medicine
Vaccination strategies to reduce the risk of leukaemia and melanoma
John M Grange MSc MD
John L Stanford MD
Cynthia A Stanford SRN
Klaus F Kölmel MD 1
Department of Medical Microbiology, Royal Free and University College
Medical School, Windeyer Institute for Medical Sciences, 46 Cleveland Street,
London W1T 4JF, UK
1 Department of Dermatology, University of Göttingen, Von-Siebold-Strasse
3, D-37075 Göttingen, Germany
Correspondence to: Professor J L Stanford E-mail:
j.stanford{at}ucl.ac.uk
 |
INTRODUCTION
|
|---|
In the industrialized world, the burden of infectious disease
has been
vastly reduced by improved standards of hygiene in
the home and public places.
But numerous studies, reviewed
elsewhere,
1-3
suggest
that a price may be paid in the rising incidence of diseases
such as
asthma and autoimmune disorders. According to this hypothesis,
the maturing
immune system no longer encounters the many microbiological
challenges that
evolution has led it to expect,
and which contribute to its
maturation and pathways of regulationin
other words, to its
education.
Some of the recent reviews of this hygiene
hypothesis1,3
suggest that the postulates might be extended to other disorders with an
immunological element, notably certain cancers. The ability of serious
infections to induce regression of cancers has long been recognized. The
phenomenon was observed in the 19th century in England, Germany and the USA
by, respectively, Campbell De
Morgan,4
Bruns5 and
Coley.6 Coley
induced erysipelas therapeutically in patients with sarcoma, with beneficial
results in several cases. Since this was very risky in those pre-antibiotic
days, he then experimented with extracts of streptococci and other bacteria
and found these Coley toxins to be likewise effective.
Not only may infections have an effect on established cancers but it is
also possible that, by eliciting or enhancing antitumour immunity, they reduce
the risk of tumours subsequently developing. In this context, Greaves observed
that acute leukaemia, the commonest malignancy seen in children, occurs
particularly in affluent
societies.7 He
therefore postulated that the disease is associated with an abnormal response
to common infections of infancy and childhood associated with the altered
environment of such societies. According to Greaves' hypothesis, the
biological norm is for the very young to encounter numerous
infections, from the mother around the time of birth and from siblings and
other contacts in infancy. Greaves therefore postulated that such infections
would modulate the developing immune system, involving the expansion,
suppression and elimination of certain T-cell subsets, in line with evolution,
and that lifestyles in developed countries, with reduced exposure to such
infections, would compromise this evolutionary adaptation of the immune
system. The immune proliferative stress resulting from an
abnormal maturation of the immune system would favour mutations responsible
for leukaemia. (It must be emphasized that Greaves' hypothesis refers to
factors affecting the maturation of an intrinsically normal immune system.
This is quite distinct from congenital or acquired immunosuppressive disorders
which are associated with an increased risk of lymphomas rather than of
leukaemia.)
Greaves' hypothesis has received strong support from studies in France and
the
USA.8,9
Both pointed to a relation between protection against acute lymphoblastic
leukaemia and exposure to common infections as a result of daycare attendance,
and demonstrated that the degree of such protection was related to the amount
of time spent in daycare facilities. The French study also related protection
to repeated early common infections, surgical procedures for ear, nose and
throat infections and prolonged breastfeeding. The latter, according to
Greaves, has multiple immunological effects on the infant and results in the
oral transmission of bacteria and viruses that contribute to normal immune
maturation.
 |
HYGIENE, LEUKAEMIA AND ALLERGIESA LINK?
|
|---|
It is noteworthy that the factors protecting against leukaemia
are among
those that have been shown to protect children against
allergies and asthma,
both of which are on the rise in affluent
nations.
10
Protection
against these disorders has been associated with exposure to
farmyard
muck, bacteria transmitted by the faecal-oral route, time spent
in
daycare facilities and having older siblings (presumably
because they bring
infections home from school). Of 53 studies
included in a
meta-analysis,
11 48
revealed a protective effect
of having older siblings on various allergic
disorders including
eczema (9 of 11 studies), asthma and wheezing (21 of 31)
and
hayfever (17 of 17). The authors emphasize that the reviewed
studies were
purely epidemiological in nature and shed no light
on the mechanism. While the
hygiene hypothesis could explain
at least some of the observed findings, other
factors (for instance,
endocrine and
in utero programming) merit
consideration.
In addition, there are reports from the 1920s showing that, although
patients with asthma or hayfever were often tuberculin positive, injections of
small amounts of tuberculin appeared to be
curative.12 More
recently tuberculin positivity, indicative of exposure to mycobacterial
antigens by BCG vaccination, infection with Mycobacterium
tuberculosis or, possibly, sensitization to environmental mycobacteria,
was shown to confer protection against atopic disorders in
Japan.13 This
raises the question of whether natural infection by mycobacteria might
contribute to immune maturation and protection against childhood leukaemia.
Between 1911 and 1959 the UK saw the incidence of this disease rising by 4.5%
a year, and this was a time when young children were becoming much less at
risk of infection by milk-borne M. bovis, firstly as a result of
pasteurization of milk and subsequently by removal of reactor
cattle.14 Clearly,
many other socioeconomic changes could, as suggested by Greaves, have led to
alterations in immune maturation accounting for the increase in the incidence
of leukaemia over that period, but mycobacterial infections as a factor in
protection against leukaemia cannot be readily dismissed.
These observations pose the question of whether vaccination with BCG, an
attenuated derivative of M. bovis, affords protection against
leukaemia. On initial examination, the published work is confusing and
contradictory. Studies in several countries, including the USA, Canada,
Australia, Finland and Israel, showed that BCG vaccination protected against
leukaemia and other malignancies of childhood and
adolescence.15 On
the other hand, a study of New Zealand children vaccinated at the age of 13
years showed no
protection,16 while
one conducted by Comstock in Alabama suggested that there might even be a
slight increase in
risk.17 On
re-evaluation of these reports, it became apparent that protection against
leukaemia and, in some studies, other cancers was seen only in regions where
BCG was given neonatally and in which it afforded protection against
tuberculosis.15
 |
LEUKAEMIA, MELANOMA AND VACCINATION
|
|---|
It is possible that, in line with the hypothesis of Greaves,
BCG
vaccination beneficially affects maturation of the immune
system in
environments where other expected stimuli
are reduced or absent.
A different, but not incompatible, hypothesis
was proposed by Rosenthal who,
in studies conducted in Chicago,
was the first to observe that neonatal BCG
vaccination reduced
the incidence of leukaemia and other malignancies in
childhood.
18
Rosenthal
postulated that one important function of T-cell-mediated immunity
early
in life is to seek and remove embryonic remnants capable of
developing
into cancers, and that this function could be stimulated
by certain infections
or vaccines (especially BCG) that induce
cellular immune responses rather than
antibody production. It
is thus noteworthy that in Africa BCG, but not
vaccines such
as tetanus and diphtheria that primarily induce antibody
production,
seems to have beneficial impacts on general health beyond the
specific
infections against which it is
aimed.
19
Another cancer affected by previous vaccination is melanoma. A major study
conducted in seven European countries and Israel under the auspices of the
European Organization for Research for Treatment of Cancer (EORTC) showed that
persons who had received BCG or smallpox vaccination, or both, had about half
the risk of subsequently developing melanoma than unvaccinated control
subjects matched for sex, age and ethnic
origin.20 The
protection was greatest in younger persons (under 50 years of age). No
protection was seen in Dijon, France, and indeed there was a non-significant
trend towards an increased risk. The fact that this was the only centre that
used the Institut Pasteur strain of BCG raises the possibility that daughter
strains of BCG vary in protective efficacy against cancer. This might, for
example, explain why Costa Rica, which practises neonatal BCG vaccination, has
a high incidence of childhood leukaemia.
In another study, the EORTC group found that certain uncommon and severe
infections with high fever (over 38.5°C), including pulmonary tuberculosis
and sepsis due to Staphylococcus aureus, were associated with a
subsequent reduced risk of
melanoma.21 Less
severe infections associated with high fever, such as influenza, afforded only
slight protection, although repeated infections of this type enhanced the
protection. Limited published evidence suggests that febrile infections may
afford some protection against other
cancers.22,23
 |
CELLULAR BASIS OF PROTECTION AGAINST CANCER
|
|---|
The cellular basis of protection against cancer by natural infection
or
certain vaccinations is poorly understood, as are the underlying
mechanisms of
immune regulation. It is, however, noteworthy
that infants are born with a
weak Th2 polarization which subsequently
switches to a Th1
profile.
24 This
switch is facilitated by environmental
factors, principally bacterial
infections,
2,25
and an absence
of such factors could lead to the observed increase in the
incidence
of atopic disorders by facilitating a Th2 drift.
Likewise,
there have been several reports of an association of cancer
with a
Th2 drift and in some instances the extent of the drift
was related to the
extent of the disease or was a predictor
of poor
outcome.
26
In this context, neonatal BCG vaccination induces or enhances Th1
responses.27
Although cause and effect are hard to separate, beneficial effects on cancer
induced by immunotherapy with BCG or heat-killed M. vaccae have been
associated with shifts towards Th1 cytokine
production.28,29
In considering the impact of environmental factors in diseases associated
with immune dysfunction, one must bear in mind that there are several, and
probably many, types and patterns of such dysfunction. In all probability, the
observed Th1 and Th2 balances and functions are merely superficial aspects of
complex immunoregulatory networks and disturbances of the same, with many
positive and negative feedback phenomena. Thus, autoimmune diseases are
associated with either Th1 or Th2 activity and leprosy reveals a
clinicopathological spectrum related to different forms of immune
dysfunction.
For this reason, although immune dysregulation may underlie increased risk
of allergic disorders and cancer, the relation between the two classes of
disease may be complex and even paradoxical. Thus, although some studies
indicate that allergy is associated with an increased risk of cancer, others
show no association or even apparent protection. When Eriksson et
al.30 looked
for allergy in a cohort of 6593 patients with cancer they found complex
relations between the conditions and called for studies on the exact
immunological basis of the allergy and the organ specificity and type of
cancer.30 As an
example of the complexity of such relations, atopy appeared to be associated
with a reduced risk of melanoma: 4.2% of melanoma patients were
atopic compared with 10% of
controls.31 A
suggested explanation is that atopic subjects are more prone to febrile
infections which, as outlined above, are associated with protection against
melanoma. Another is that atopic dermatitis, beginning early in life, leads to
a reduction in the number of pigmented naevi in the
skin,32 where
melanomas commonly originate.
 |
CONCLUSION
|
|---|
Whatever the mechanism, and however complex the immune interactions,
there
is growing evidence that various environmental factors,
specific infectious
diseases, regular exposure to low-grade
infections and certain vaccination
strategies affect the subsequent
incidence of acute leukaemia, melanoma and
possibly other cancers.
As the incidence of these diseases, with their need
for burdensome
and distressing therapy, is increasing in the affluent world,
strategies
based on ensuring a more natural maturation of the immune system
would
be of great benefit. This is especially so in view of increasing
evidence
that the incidence of other diseases as diverse as asthma, allergy
and
autoimmune diseases is adversely affected by the same maturation
defects.
Clearly, nobody would advocate a return to the era
of widespread and
uncontrolled epidemics of childhood infection.
Rather, a simple preventive
strategynamely, universal
neonatal BCG vaccinationand
encouragement of lifestyles
favouring a more natural maturation of the immune
system, should
receive prompt and serious consideration. Thereby, the
empirical
observations of Campbell De Morgan published in 1874 could at
last
be translated into a rational and simple means of reversing
the rising tide of
cancer in many parts of the
world.
33
 |
REFERENCES
|
|---|
- Stanford JL, Stanford CA, Grange JM. Environmental echoes.
Science Progr2001; 84(Pt 2):105
-24
- Martinez FD, Holt PG. Role of microbial burden in aetiology of
allergy and asthma. Lancet1999; 354(suppl 2):12
-15[CrossRef]
- Bach J-F. The effect of infections on susceptibility to autoimmune
and allergic diseases. N Engl J Med2002; 347:911
-20[Free Full Text]
- De Morgan C. Observations on cancer. Lancet1874; i:323
-9
- Bruns P. Die Heilwirkung des Erysipels auf Geschwulste.
Beitr Klin Chir1887-1888; 3:443
- Coley WB. The treatment of malignant tumors by repeated
inoculations of erysipelas. Historical article of 1882, reprinted in
Clin Orthop1991; 262:3
-11
- Greaves MF. Aetiology of acute leukaemia.
Lancet1997; 349:344
-9[CrossRef][Medline]
- Perrillat F, Clavel J, Auclerc MF, et al. Day-care, early
common infections and childhood acute leukaemia: a multicentre French
case-control study. Br J Cancer2002; 86:1064
-9[CrossRef][Medline]
- Ma X, Buffler PA, Selvin S, et al. Daycare attendance and
risk of childhood acute lymphoblastic leukaemia. Br J
Cancer 2002;86:1419
-24[CrossRef][Medline]
- Woolcock AJ, Peat JK. Evidence for the increase in asthma
worldwide. Ciba Found Symp1997; 206:122
-34[Medline]
- Karmaus W, Botezan C. Does a higher number of siblings protect
against the development of allergy and asthma? A review. J Epid
Commun Hlth 2002;56:209
-17
- Storm van Leeuwen W, Varekamp H. On the tuberculin treatment of
bronchial asthma and hay fever. Lancet1921; ii:1366
-9
- Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse
association between tuberculin response and atopic disorder.
Science1997; 275:77
-9[Abstract/Free Full Text]
- Grange JM, Stanford JL. The aetiology of childhood leukaemia.
Arch Dis Child1994; 70:553
-4
- Grange JM, Stanford JL. BCG vaccination and cancer.
Tubercle1990; 71:61
-4[CrossRef][Medline]
- Skegg DCG. BCG vaccination and the incidence of lymphomas and
leukaemia. Int J Cancer1975; 21:18
-21
- Comstock GW. Leukaemia and BCG, a controlled trial.
Lancet1971; ii:1062
-3
- Rosenthal SR. Cancer precursors and their control by BCG.
Develop Biol Stand1986; 58:401
-16
- Kristensen I, Aaby P, Jensen H. Routine vaccinations and child
survival: follow up study in Guinea-Bissau, West Africa.
BMJ2000; 321:1435
-9[Abstract/Free Full Text]
- Pfahlberg A, Kölmel KF, Grange JM, et al. Inverse
association between melanoma and previous vaccinations against tuberculosis
and smallpox: results of the FEBIM study. J Invest
Dermatol 2002;119:570
-5[CrossRef][Medline]
- Kömel KF, Pfahlberg A, Mastrangelo G, et al.
Infections and melanoma risk: results of a multicentre EORTC case-control
study. Melanoma Res1999; 9:511
-19[Medline]
- Abel U, Becker N, Angerer R, et al. Common infections in
the history of cancer patients and controls. J Cancer Res Clin
Oncol 1991;117:339
-44[CrossRef][Medline]
- Albonico HU, Bräker HU, Hüsler J. Febrile infectious
childhood diseases in the history of cancer patients and matched controls.
Med Hypoth1998; 51:315
-20[CrossRef][Medline]
- Holt PG. Potential role of environmental factors in the etiology
and pathogenesis of atopy: a working model. Environ Health
Perspect 1999;
107(suppl 3):485
-7
- Rook GA, Stanford JL. Give us this day our daily germs.
Immunol Today1998; 19:113
-16[CrossRef][Medline]
- Stanford JL, Stanford CA, Baban B, Grange JM. Therapeutic
vaccination for cancer: the potential value of mycobacterial products.
Int J Pharmaceut Med1999; 12:191
-5
- Marchent A, Goetghebeur T, Ota MO, et al. Newborns develop
a Th1-type immune response to Mycobacterium bovis bacillus
Calmette-Guérin vaccination. J Immunol1999; 163:2249
-55[Abstract/Free Full Text]
- Kaempfer R, Gerez L, Farbstein H, et al. Prediction of
response to treatment in superficial bladder carcinoma through pattern of
interleukin-2 gene expression. J Clin Oncol1996; 14:1778
-86[Abstract/Free Full Text]
- Maraveyas A, Baban B, Kennard D, et al. Possible improved
survival of patients with stage IV AJCC melanoma receiving SRL 172
immunotherapy: correlation with induction of increased levels of intracellular
interleukin-2 in peripheral blood leucocytes. Ann
Oncol 1999;10:817
-24[Abstract/Free Full Text]
- Eriksson NE, Holmén A, Högstedt B, Mikoczy Z, Hagmar L.
A prospective study of cancer incidence in a cohort examined for allergy.
Allergy1995; 50:718
-22[Medline]
- Kölmel KF, Compagnone D. Melanom und Atopie.
Deutsche Med Wochenschr1988; 113:169
-71
- Broberg A, Augustsson A. Atopic dermatitis and melanocytic naevi.
Br J Dermatol2000; 142:306
-9[CrossRef][Medline]
- Grange JM, Stanford JL, Stanford CA. Campbell De Morgan's
Observations on cancer, and their relevance today. J
R Soc Med 2002;95:296
-9[Free Full Text]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Mastrangelo, J. M. Grange, E. Fadda, U. Fedeli, A. Buja, and J. H. Lange
Lung Cancer Risk: Effect of Dairy Farming and the Consequence of Removing that Occupational Exposure
Am. J. Epidemiol.,
June 1, 2005;
161(11):
1037 - 1046.
[Abstract]
[Full Text]
[PDF]
|
 |
|